Skip to main content
. 2022 Dec 26;11:107. doi: 10.1186/s40164-022-00361-3

Table 1.

Correlations between ECT2 expression and clinic-pathological features of 120 breast cancer patients in immunohistochemistry chip (HBreD145Su01)

Variables N ECT2 expression P value
< 8 (low expression)  ≥ 8 (high expression)
Age 0.224a
 < Median(51) 57 28 29
 ≥ Median (51) 63 24 39
Tumor location 0.961a
 Left 58 25 33
 Right 62 27 35
Grade 0.073a
 Grade 1 25 16 9
 Grade 2 90 44 56
Stage 0.043a
 Stage I–II 75 37 38
 Stage III–IV 43 13 30
Subtype 0.0041a
 Luminal 89 46 43
 Her2 enriched 13 4 9
 Basal 18 2 16

aPearson Chi-square test